Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 482 - 492Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Bibliography
Bozier, J, Chivers, EK, Chapman, DG, et al. The evolving landscape of e-cigarettes: a systematic review of recent evidence. Chest 2020; 157: 1362.Google Scholar
Hajek, P, Phillips-Waller, A, Przulj, D, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. N Engl J Med 2019; 380: 629.Google Scholar
Hartnett, KP, Kite-Powell, A, Patel, MT, et al. Syndromic surveillance for e-cigarette or vaping product use-associated lung injury. N Engl J Med 2020; 382: 766.Google Scholar
Jonas, AM, Raj, R. Vaping-related acute parenchymal lung injury: a systematic review. Chest 2020; 158: 1555.Google Scholar
Kiernan, E, Click, ES, Melstrom, P, et al. A brief overview of the national outbreak of e-cigarette, or vaping, product use-associated lung injury and the primary causes. Chest 2021; 159: 426.CrossRefGoogle ScholarPubMed
Kligerman, SJ, Kay, FU, Raptis, CA, et al. CT findings and patterns of e-cigarette or vaping product use-associated lung injury. Chest 2021; 160: 1492.CrossRefGoogle ScholarPubMed
Shao, XM, Fang, ZT. Severe acute toxicity of inhaled nicotine and e-cigarettes: seizures and cardiac arrhythmia. Chest 2020; 157: 506.CrossRefGoogle ScholarPubMed
Werner, AK, Koumans, EH, Chatham-Stephens, K, et al. Hospitalizations and deaths associated with EVALI. N Engl J Med 2020; 382: 1589.Google Scholar
Bibliography
Chaves, SS, Gargiullo, P, Zhang, JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med 2007; 356: 1121.Google Scholar
Cohen, JI, Brunell, PA, Straus, SE, et al. Recent advances in varicella-zoster virus infection. Ann Intern Med 1999; 130: 922.CrossRefGoogle ScholarPubMed
Dwyer, DE, Cunningham, AL. Herpes simplex and varicella-zoster virus infections. Med J Aust 2002; 177: 267.Google Scholar
Gilden, DH, Kleinschmidt-DeMasters, BK, LaGuardia, JJ, et al. Neurologic complications of reactivation of varicella-zoster virus. N Engl J Med 2000; 342: 636.Google Scholar
Oxman, MN, Levin, MJ, Johnson, GR, et al. A vaccine to prevent herpes zoster and postherpetic neuralgia in older patients. N Engl J Med 2005; 352: 2271.Google Scholar
Straus, SE, Ostrove, JM, Inchauspe, G, et al. Varicella-zoster virus infections: biology, natural history, treatment, and prevention. Ann Intern Med 1988; 108: 221.Google Scholar
Strassels, SA, Sullivan, SD. Clinical and economic considerations of vaccination against varicella. Pharmacotherapy 1997; 17: 133.Google Scholar
Bibliography
Arend, WP, Michel, BA, Bloch, DA, et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129.Google Scholar
Booher, AM, Eagle, KA. Diseases of the aorta. In: Scientific American Medicine. Cardiovascular Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Bourrillon, A. Kawasaki’s disease: multiple and various aspects. Arch Pediatr 2008; 15: 825.CrossRefGoogle ScholarPubMed
Calabrese, L, Dune, G, Lie, J. Vasculitis in the central nervous system. Arthritis Rheum 1997; 40: 1189.Google Scholar
Carter, MJ, Shankar-Hari, M, Tibby, SM. Paediatric inflammatory multisystem syndrome temporally-associated with SARS-CoV-2 infection: an overview. Intens Care Med 2021; 47: 90.CrossRefGoogle ScholarPubMed
Feldstein, LR, Rose, EB, Horwitz, SM, et al. Multisystem inflammatory syndrome in US children and adolescents. N Engl J Med 2020; 383: 334.Google Scholar
Frankel, SK, Cosgrove, GP, Fischer, A, et al. Update in the diagnosis and management of pulmonary vasculitis. Chest 2006; 129: 452.Google Scholar
Gatenby, PA. Anti-neutrophil cytoplasmic antibody-associated systemic vasculitis: nature or nurture? Intern Med J 2012; 42: 351.Google Scholar
Gibson, LE. Cutaneous vasculitis: approach to diagnosis and systemic associations. Mayo Clin Proc 1990; 65: 221.Google Scholar
Hamilton, CR, Shelley, WM, Tumulty, PA. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine 1971; 50: 1.Google Scholar
Han, RK, Sinclair, B, Newman, A, et al. Recognition and management of Kawasaki disease. CMAJ 2000; 162: 807.Google Scholar
Hunder, GG, Bloch, DA, Michel, BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122.Google Scholar
Jayne, DRW, Davies, MJ, Cox, CJV, et al. Treatment of systemic vasculitis with pooled intravenous immunoglobulin. Lancet 1991; 337: 1137.Google Scholar
Jennette, JC, Falk, RJ, Andrassy, K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187.Google Scholar
Kerr, GS, Hallahan, CW, Giordano, J, et al. Takayasu arteritis. Ann Intern Med 1994; 120: 919.Google Scholar
Lie, JT. Classification and immunodiagnosis of vasculitis: a new solution or promises unfulfilled? J Rheumatol 1988 15: 728.Google Scholar
Lupi-Herrera, E, Sanchez-Torres, G, Marcushamer, J, et al. Takayasu’s arteritis: clinical study of 107 cases. Am Heart J 1997; 93: 94.Google Scholar
Mehregan, RD, Hall, MJ, Gibson, LE. Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 1992; 26: 441.Google Scholar
Moore, PM. Diagnosis and management of isolated angiitis of the central nervous system. Neurology 1989; 39: 167.Google Scholar
Numano, F, Kobayashi, Y. Takayasu arteritis: beyond pulselessness. Intern Med 1999; 38: 226.Google Scholar
Oz, MC, Brener, BJ, Buda, JA, et al. A ten-year experience with bacterial aortitis. J Vasc Surg 1989; 10: 439.Google Scholar
Riphagen, S, Gomez, X, Gonzales-Martinez, C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet 2020; 395: 1607.Google Scholar
Royle, J, Williams, K, Elliott, E, et al. Kawasaki disease in Australia, 1993–95. Arch Dis Child 1998; 78: 33.Google Scholar
Savage, COS, Harper, L, Adu, D. Primary systemic vasculitis. Lancet 1997; 349: 553.CrossRefGoogle ScholarPubMed
Sheikhzadeh, A, Tettenborn, I, Noohi, F, et al. Occlusive thromboaortopathy (Takayasu disease): clinical and angiographic features and a brief review of literature. Angiology 2002; 53: 29.CrossRefGoogle Scholar
Villa-Forte, A, Mandell, BF. Systemic vasculitis syndromes. In: Scientific American Medicine. Rheumatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Zilko, PJ. Polymyalgia rheumatica and giant cell arteritis. Med J Aust 1996; 165: 438.Google Scholar
Bibliography
Gordon, AC, Russell, JA, Walley, KR, et al. The effects of vasopressin on acute kidney injury in septic shock. Intens Care Med 2010; 36: 83.Google Scholar
Holmes, CL, Patel, BM, Russell, JA, et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001; 120: 989.Google Scholar
Russell, JA, Walley, KR, Singer, J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358: 877.Google Scholar
Bibliography
Furman, JM, Cass, SP. Benign paroxysmal positional vertigo N Engl J Med 1999; 341: 1590.Google Scholar
Harrison, MS. ‘Epidemic vertigo’ – ‘vestibular neuronitis’: a clinical study. Brain 1962; 85: 613.Google Scholar
Rivlin, W, Habershon, C, Tsang, BK-T, et al. Practical approach to vertigo: a synthesis of the emerging evidence. Intern Med J 2022; 52: 356.Google Scholar
Strupp, M, Zingler, VC, Arbusow, V, et al. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351: 354.Google Scholar
Tsang, BKT, Chen, ASK, Paine, M. Acute evaluation of the acute vestibular syndrome: differentiating posterior circulation stroke from acute peripheral vestibulopathies. Intern Med J 2017; 47: 1352.Google Scholar
Bibliography
Katz, SI, Hall, RP, Lawlwy, TJ, et al. Dermatitis herpetiformis: the skin and the gut. Ann Intern Med 1980; 93: 857.Google Scholar
Levitt, J, Czernik, A, Koo, B. Vesiculobullous diseases. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Sehgal, VN, Gangwani, OP. Fixed drug eruption: current concepts. Int J Dermatol 1987; 26: 67.Google Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Howard, CR. Viral hemorrhagic fevers: properties and prospects for treatment and prevention. Antiviral Res 1984; 4: 169.Google Scholar
Bibliography
Amrein, K, Oudemans-van, Straaten, Berger, MM. Vitamin therapy in critically ill patients: focus on thiamine, vitamin C and vitamin D. Intens Care Med 2018; 44: 1940.Google Scholar
Anderson, JJB, Toverud, SU. Diet and vitamin D: a review with an emphasis on human function. J Nutr Biochem 1994; 5: 58.Google Scholar
Casaer, MP, Bellomo, R. Micronutrient deficiency in critical illness: an invisible foe? Intens Care Med 2019; 45: 1136.Google Scholar
Chandra, RK. Effect of vitamin and trace-element supplementation on immune responses and infection in elderly patients. Lancet 1992; 340: 1124.Google Scholar
Heyland, DK, Dhaliwal, R, Suchner, U, et al. Antioxidant nutrients: a systematic review of trace elements and vitamins in the critically ill patient. Intens Care Med 2005; 31: 327.Google Scholar
Kennedy, M. The vitamin epidemic: what is the evidence for harm or value? Intern Med J 2018; 40: 901.Google Scholar
Ordonez-Moran, P, Larriba, MJ, Pendas-Franco, N, et al. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 2005; 10: 2723.Google Scholar
Shenkin, A. Vitamin and essential trace element recommendations during intravenous therapy: theory and practice. Proc Nutr Soc 1986; 45: 383.Google Scholar
Thomas, MK, Lloyd-Jones, DM, Thadhani, RI, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998; 338: 777.Google Scholar
Bibliography
Romain, M, Sviri, S, Linton, DM, et al. The role of vitamin B12 in the critically ill – a review. Anaesth Intens Care 2016; 44: 447.Google Scholar
Bibliography
Carr, AC, Shaw, GM, Fowler, AA, et al. Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock? Crit Care 2015; 19: 418.Google Scholar
Fuji, T, Luethi, N, Young, PJ, et al. Effect of vitamin C, hydrocortisone, and thiamine vs hydrocortisone alone on time alive and vasopressor support among patients with septic shock: the VITAMINS randomized clinical trial. JAMA 2020; 323: 423.Google Scholar
Hooper, MH, Hager, DN. Understanding vitamin C in critical illness: focus on dose, route, and disease. Crit Care Med 2019; 47: 867.Google Scholar
Long, CL, Maull, KI, Krishnan, RS, et al. Ascorbic acid dynamics in the seriously ill and injured. J Surg Res 2003; 109: 144.Google Scholar
Marik, PE. Vitamin C for the treatment of sepsis: the scientific rationale. Pharmacol Ther 2018; 189: 63.Google Scholar
Marik, P, Khangora, V, Rivera, R, et al. Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study. Chest 2017; 151: 1229.Google Scholar
McNamara, R, Deane, A, Anstey, J, et al. Understanding the rationale for parenteral ascorbate (vitamin C) during an acute inflammatory reaction: a biochemical perspective. Crit Care Resusc 2018; 20: 174.Google Scholar
Mohammed, BM, Fisher, BJ, Kraskauskas, D, et al. Vitamin C: a novel regulator of neutrophil extracellular trap formation. Nutrients 2013; 5: 3131.Google Scholar
Moskowitz, A, Huang, DT, Hou, PC, et al. Effect of ascorbic acid, corticosteroids, and thiamine on organ injury in septic shock: the ACTS randomized clinical trial. JAMA 2020; 324: 642.Google Scholar
Oudemans-van Straaten, HM, Elbers, PW, Spoelstra-de Man, AME. How to give vitamin C a cautious but fair chance in severe sepsis. Chest 2017; 151: 1199.Google Scholar
Putzu, A, Daems, A-M, Lopez-Delgado, JC, et al. The effect of vitamin C on clinical outcome in critically ill patients: a systematic review with meta-analysis of randomized clinical trials. Crit Care Med 2018; 47: 774.Google Scholar
Yanase, F, Fujii, T, Naorungroj, T, et al. Harm of high-dose vitaimin C therapy in adult patients: a scoping review. Crit Care Med 2020;Google Scholar
Bibliography
Amrein, K, Christopher, KB, McNally, JD. Understanding vitamin D deficiency in intensive care patients. Intens Care Med 2015; 41: 1961.Google Scholar
Anderson, JJB, Toverud, SU. Diet and vitamin D: a review with an emphasis on human function. J Nutr Biochem 1994; 5: 58.Google Scholar
Cancer Council of Australia, in conjunction with the Australasian College of Dermatologists, the Australian and New Zealand Bone and Mineral Society, the Endocrine Society of Australia and Osteoporosis Australia. Position statement: sun exposure and vitamin D – risks and benefits. 2016. http://wiki.cancer.org.au/policy/Position_statement_-_Risks_and_benefits_of_sun_exposureGoogle Scholar
Ginde, AA, Brower, RG, Caterino, JM, et al. Early high-dose vitamin D3 for critically ill, vitamin D-deficient patients. N Engl J Med 2019; 381: 2529.Google Scholar
Joshi, D, Center, JR, Eisman, JA. Vitamin D deficiency in adults. Aust Prescriber 2010; 33: 103.Google Scholar
Lai, JKC, Lucas, RM, Banks, E, et al. Variability in vitamin D assays impairs clinical assessment of vitamin D status. Intern Med J 2012; 42: 43.Google Scholar
Lee, P, Eisman, JA, Center, JR. Vitamin D deficiency in critically ill patients. N Engl J Med 2009; 360: 1912.Google Scholar
Moromizato, T, Litonjua, AA, Braun, AB, et al. Association of low serum 25-hydroxyvitamin D levels and sepsis in the critically ill. Crit Care Med 2014; 42: 97.Google Scholar
Ordonez-Moran, P, Larriba, MJ, Pendas-Franco, N, et al. Vitamin D and cancer: an update of in vitro and in vivo data. Front Biosci 2005; 10: 2723.Google Scholar
Reid, IR, Bolland, MJ. Controversies in medicine: the role of calcium and vitamin D supplements in adults. Med J Aust 2019; 211: 468.Google Scholar
Bibliography
Berkner, KL, Runge, KW. The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis. J Thromb Haemost 2004; 2: 2118.Google Scholar
Dam, H. The antihaemorrhagic vitamin of the chick: occurrence and chemical nature. Nature 1935; 135: 652.Google Scholar
Dowd, P, Ham, S-W, Naganathan, S, et al. The mechanism of action of vitamin K. Annu Rev Nutr 1995; 15: 419.Google Scholar
Hasific, S, Ovrehus, KA, Gerke, O, et al. Extent of arterial calcification by conventional vitamin K antagonist treatment. PLoS ONE 2020; 15: e0241450.Google Scholar
Lerner, RG, Aronow, WS, Sekhri, A, et al. Warfarin use and the risk of valvular calcification. J Thromb Haemost 2009; 7: 2023.Google Scholar
Presnell, SR, Stafford, DW. The vitamin K-dependent carboxylase. Thromb Haemost 2002; 87: 937.Google Scholar
Stenflo, J, Fernlund, P, Egan, W, et al. Vitamin K dependent modifications of glutamic acid residues in prothrombin. Proc Natl Acad Sci 1974; 71: 2730.Google Scholar
Tie, J-K, Stafford, DW. Structural and functional insights into enzymes of the vitamin K cycle. J Thromb Haemost 2016; 14: 236.Google Scholar
Yang, Y, Liu, T, Zhao, J, et al. Warfarin-related nephropathy: prevalence, risk factors and prognosis. Int J Cardiol 2014; 176: 1297.Google Scholar
Bibliography
Bloom, AL. Von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc 1991; 66: 743.Google Scholar
Lenting, PJ, Casari, C, Christophe, OD, et al. Von Willebrand factor: the old, the new and the unknown. J Thromb Haemost 2012; 10: 2428.Google Scholar
Michiels, JJ, ed. Diagnosis and management of congenital von Willebrand’s disease. Semin Thromb Hemost 2002; 28: 109.Google Scholar
Mohri, H. Acquired von Willebrand syndrome: features and management. Am J Hematol 2006; 81: 616.CrossRefGoogle Scholar
Oldenburg, J, Schwaab, R. Molecular biology of blood coagulation. Semin Thromb Hemost 2001; 27: 313.Google Scholar
Patmore, S, Dhami, SPS, O’Sullivan, JM. Von Willebrand factor and cancer: metastasis and coagulopathies. J Thromb Haemost 2020; 18: 2444.Google Scholar
Sadler, JE, Budde, U, Eikenboom, JCJ, et al. Update on the pathophysiology and classification of von Willebrand disease. J Thromb Haemost 2006; 4: 2103.Google Scholar
Sadler, JE, Mannucci, PM, Berntorp, E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost 2000; 84: 160.Google Scholar
Seaman, CD, Yabes, J, Comer, DM, et al. Does deficiency of von Willebrand factor protect against cardiovascular disease? Analysis of a national discharge register. J Thromb Haemost 2015; 13: 1999.Google Scholar
Veyradier, A, Jenkins, CSP, Fressinaud, E, et al. Acquired von Willebrand syndrome: from pathophysiology to management. Thromb Haemost 2000; 84: 175.Google Scholar
Vincentelli, A Susen, S, Le Tourneau, T, et al. Acquired von Willebrand syndrome in aortic stenosis. N Engl J Med 2003; 349: 343.Google Scholar